TrialNeuro-oncology2010

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

Fabio M Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.